Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition | Nature Communications
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
JPM | Free Full-Text | Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer's Disease
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
IJMS | Free Full-Text | Amyloid Beta in Aging and Alzheimer’s Disease
Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives | SpringerLink
The amyloid cascade hypothesis: are we poised for success or failure? - Karran - 2016 - Journal of Neurochemistry - Wiley Online Library
Frontiers | Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor | ACS Applied Materials & Interfaces
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
The complexity of Alzheimer's disease: an evolving puzzle | Physiological Reviews
IJMS | Free Full-Text | Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease
IJMS | Free Full-Text | Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease
Measuring the Brain's Amyloid Buildup Less Effective in Identifying Severity, Progression of Alzheimer's Disease Compared to Other Imaging Methods - Penn Medicine
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study - The Lancet Neurology
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | Scientific Reports
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma - Michno - 2021 - Journal of Neurochemistry - Wiley Online Library
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease | Science Advances
Frontiers | Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals
